Norwalk virus edible vaccine - Boyce Thompson Institute for Plant Research

Drug Profile

Norwalk virus edible vaccine - Boyce Thompson Institute for Plant Research

Latest Information Update: 19 Jan 2007

Price : $50

At a glance

  • Originator Boyce Thompson Institute for Plant Research
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Norwalk virus infections

Most Recent Events

  • 05 Sep 2000 The Boyce Thompson Institute is seeking a corporate partner for continued development of the edible Norwalk virus vaccine (
  • 28 Aug 2000 A phase I trial has been added to the adverse events section and the Viral Infections immunogenicity section
  • 21 Jun 2000 Phase-I clinical trials for Norwalk virus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top